Impact Biomedical IBO Income Statement (2022-2026)

NYSE IBO
$5.14 +0.35 (+7.31%)
At close: Nov 13, 2026 · 4:00 PM EST
Reported Financials

Impact Biomedical Quarterly Income Statement

Periods 18 quarters
Latest Sep 2026

Impact Biomedical reported revenue of $0.00B and net income of -$0.00B for the quarter ended Sep 2026, up 16.7% year over year. This income statement covers 18 quarters of results from Jun 2022 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Revenue & cost
Revenue 0.05M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.02M0.01M0.01M0.00M0.02M
Cost of RevenueCost of Rev 0.00M0.00M0.42M0.00M0.01M
Gross Profit 0.01M0.02M-0.42M0.00M0.02M
Operating items
Depreciation & Amortization - TotalDep. & Amort. (Tot) 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Research & DevelopmentR&D 0.21M0.33M0.52M0.18M0.27M0.36M0.63M0.18M0.12M0.08M-0.11M0.10M0.08M0.05M0.11M0.05M0.08M0.04M
Share-based Compensation (IS)Stock Comp. 0.00M0.00M0.00M
Selling, General & AdministrativeSG&A 0.06M0.09M0.04M0.04M0.04M0.10M0.13M0.15M0.15M0.13M0.29M0.25M0.25M0.26M-0.44M1.62M0.17M0.16M
Other Operating ExpensesOther Opex 0.03M0.01M0.03M0.01M0.00M0.01M0.10M0.00M0.01M0.05M0.11M0.12M0.12M0.11M0.07M0.07M0.07M0.07M
Operating ExpensesOpex 0.80M0.89M1.03M0.80M1.01M1.08M1.14M0.77M0.63M1.13M26.23M1.01M1.16M0.97M1.18M2.30M0.71M0.67M
Operating IncomeOp. Inc -0.75M-0.89M-1.03M-0.80M-1.01M-1.08M-1.14M-0.77M-0.63M-1.13M-26.23M-1.01M-1.15M-0.95M-1.17M-2.29M-0.70M-0.65M
Non-operating items
Non Operating Interest Expenses 0.14M0.09M0.10M0.10M0.12M0.10M0.13M0.23M0.26M0.31M0.27M0.27M0.26M0.26M-1.59M
Interest & Investment IncomeInt & Inv Inc 0.09M0.00M-0.08M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.00M0.00M
Other Non Operating IncomeOther Non Op Inc. 0.05M5.67M
Non Operating IncomeNon Op. Inc. -0.05M-0.09M-0.05M-0.11M-0.10M-0.23M
Net income details
EBIT -0.75M-0.89M-1.03M-0.80M-1.01M-1.08M-1.14M-0.77M-0.63M-1.13M-26.23M-1.01M-1.15M-0.95M-1.17M-2.29M-0.70M-0.65M
EBT -0.80M-0.98M-5.25M-0.85M-1.12M-1.18M-1.26M-1.00M-0.88M4.24M-27.10M-1.28M-14.35M-1.48M2.66M-2.28M-0.70M-0.64M
Tax ProvisionsTaxes 1.26M-1.88M
Income After Tax -0.80M-2.24M-3.37M-0.85M-1.12M-1.18M-1.26M-1.00M-0.88M4.24M-27.10M-1.28M-14.35M-1.48M2.66M-2.28M-0.70M-0.64M
Income from Continuing OperationsIncome (Continuing) -0.80M-2.24M-3.37M0.19M-1.12M0.02M0.03M0.04M-0.88M0.01M0.03M0.01M0.01M0.01M0.01M0.00M0.00M0.00M
Consolidated Net IncomeConsol Net Inc. -0.80M-2.24M-3.37M-0.85M-1.12M-1.18M-1.26M-1.00M-0.88M4.24M-27.13M-1.28M-14.35M-1.48M5.24M-2.28M-0.70M-0.64M
Net Income Attributable to Noncontrolling InterestsNCI Net Income 0.07M0.07M-0.02M-0.02M-0.03M-0.04M0.01M-0.01M-0.03M-0.01M-0.01M-0.01M0.00M0.00M0.00M
Income towards Parent CompanyParent Net Inc -0.80M-2.24M-3.37M-0.85M-1.12M-1.18M-1.19M-0.96M-0.89M4.25M-27.11M-1.27M-14.35M-1.47M5.24M-2.29M-0.70M-0.65M
Net Income towards Common StockholdersNet Income -0.73M-2.17M-3.36M-0.66M-1.10M-1.16M-1.24M-0.96M-0.89M4.25M-27.11M-1.27M-14.35M-1.47M5.25M-2.29M-0.70M-0.65M
Additional items
EPS (Basic) 0.00-0.03-0.05-0.01-0.02-0.02-0.02-0.10-0.090.37-2.52-0.11-1.18-0.120.17-0.02-0.01-0.08
EPS (Diluted) 0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Shares Outstanding 3,877.28M70.50M70.50M70.50M70.50M70.50M60.25M10.00M10.00M11.50M10.76M12.06M12.19M12.19M31.55M107.79M107.82M8.54M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 3,877.28M70,496.04M70,496.04M70,496.04M3,877.28M70,496.04M60,248.08M10,000.00M9,996.71M72,000.00M10,757.15M12,062.74M12,185.41M965.61M31,550.46M107,785.68M107,821.23M8,544.07M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 3,877.28M70.50M70.50M70.50M70.50M70.50M60.25M10.00M10.00M11.50M11.50M12.09M12.19M12.19M31.55M107.82M107.82M8.54M
EBITDA -0.47M-0.61M-0.75M-0.52M-0.73M-0.80M-0.86M-0.49M-0.35M-0.85M-25.95M-0.73M-0.87M-0.66M-0.88M-2.00M-0.42M-0.36M
Interest ExpensesInt Expense 0.14M0.09M0.10M0.10M0.12M0.10M0.13M0.23M0.26M0.31M0.27M0.27M0.26M0.26M-1.59M

Impact Biomedical Income Statement API

Pull Impact Biomedical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IBO&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY